The firm will test additional doses and use its proprietary drug response predictor to gather data that can inform a registrational study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback